Total Payments
$4,468
2024 Payments
$1,213
Companies
36
Transactions
252
Medicare Patients
1,504
Medicare Billing
$184,699
Payment Breakdown by Category
Food & Beverage$4,453 (99.7%)
Education$14.85 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,453 | 251 | 99.7% |
| Education | $14.85 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $755.13 | 48 | $0 (2024) |
| Indivior Inc. | $714.27 | 46 | $0 (2024) |
| Lilly USA, LLC | $464.41 | 25 | $0 (2024) |
| Novo Nordisk Inc | $424.13 | 25 | $0 (2024) |
| Alkermes, Inc. | $317.56 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $167.12 | 8 | $0 (2024) |
| Abbott Laboratories | $161.37 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $136.33 | 7 | $0 (2022) |
| Orexo US, Inc. | $113.22 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $105.18 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,213 | 62 | Indivior Inc. ($374.57) |
| 2023 | $1,163 | 70 | Indivior Inc. ($241.99) |
| 2022 | $1,012 | 55 | ABBVIE INC. ($219.99) |
| 2021 | $1,079 | 65 | Novo Nordisk Inc ($171.45) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: OUD | ||||||
| 12/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Opioid Use Disorder | ||||||
| 12/09/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/03/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: OUD | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: RETT SYNDROME | ||||||
| 11/14/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $41.77 | General |
| Category: OUD | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $3.64 | General |
| Category: OUD | ||||||
| 10/10/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $43.43 | General |
| Category: OUD | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Obesity | ||||||
| 09/30/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: OUD | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: OUD | ||||||
| 09/10/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: Addiction Medicine | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: OUD | ||||||
| 08/06/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: CNS | ||||||
| 08/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: OUD | ||||||
| 07/11/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: OUD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 377 | 781 | $94,145 | $49,181 |
| 2022 | 5 | 381 | 779 | $93,641 | $50,095 |
| 2021 | 6 | 383 | 792 | $95,333 | $52,590 |
| 2020 | 6 | 363 | 640 | $62,744 | $32,834 |
Total Patients
1,504
Total Services
2,992
Medicare Billing
$184,699
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 490 | $65,102 | $33,364 | 51.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 68 | 68 | $9,086 | $7,510 | 82.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 183 | $17,150 | $6,784 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $2,387 | $1,314 | 55.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 26 | $420.54 | $208.75 | 49.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 494 | $66,767 | $35,492 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 197 | $18,995 | $9,435 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 30 | 30 | $4,124 | $3,300 | 80.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $3,128 | $1,533 | 49.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 37 | 40 | $627.72 | $334.10 | 53.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 186 | 506 | $68,210 | $38,742 | 56.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 128 | 215 | $20,365 | $10,334 | 50.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $4,556 | $2,503 | 54.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 19 | $1,082 | $555.94 | 51.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 13 | 13 | $520.00 | $244.46 | 47.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $600.00 | $210.64 | 35.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 170 | 362 | $41,809 | $22,021 | 52.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 118 | 199 | $15,722 | $8,492 | 54.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 25 | 25 | $4,619 | $1,948 | 42.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 20 | 22 | $404.01 | $264.98 | 65.6% |
| 81002 | Urinalysis, manual test | Office | 2020 | 15 | 16 | $112.00 | $55.19 | 49.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 15 | 16 | $79.20 | $52.13 | 65.8% |
About Jennifer Mcmanus, C.R.N.P
Jennifer Mcmanus, C.R.N.P is a Addiction (Substance Use Disorder) healthcare provider based in Waldorf, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1689919961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Mcmanus, C.R.N.P has received a total of $4,468 in payments from pharmaceutical and medical device companies, with $1,213 received in 2024. These payments were reported across 252 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,453).
As a Medicare-enrolled provider, Mcmanus has provided services to 1,504 Medicare beneficiaries, totaling 2,992 services with total Medicare billing of $184,699. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction (Substance Use Disorder)
- Other Specialties Family
- Location Waldorf, MD
- Active Since 11/28/2012
- Last Updated 12/19/2024
- Taxonomy Code 163WA0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689919961
Products in Payments
- SUBLOCADE (Drug) $714.27
- VRAYLAR (Drug) $426.51
- VIVITROL (Drug) $249.10
- MOUNJARO (Drug) $235.58
- REXULTI (Drug) $176.99
- UBRELVY (Drug) $161.58
- Wegovy (Drug) $157.06
- TRULICITY (Drug) $156.13
- QULIPTA (Drug) $118.67
- Ozempic (Drug) $113.58
- Zubsolv (Drug) $92.46
- TRELEGY ELLIPTA (Drug) $88.72
- Saxenda (Drug) $82.72
- SHINGRIX (Biological) $78.40
- GEMTESA (Drug) $75.20
- CAPLYTA (Drug) $74.21
- FREESTYLE LIBRE 3 (Device) $70.70
- BRIXADI (Drug) $69.36
- Vivitrol (Drug) $68.46
- JARDIANCE (Drug) $65.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction (Substance Use Disorder) Doctors in Waldorf
Tonyia Johnson, M.ed., Lcadc, Lcpc, M.ED., LCADC, LCPC
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Mr. Richard Davis, Cac Ii, Ncac I, CAC II, NCAC I
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Mr. Gregoire Mcclain, Ma Lcpc Cas, MA LCPC CAS
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Kecia Wright, Lgpc, LGPC
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Menge Markmela
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)
Crystal Johnson, Cac-Ad, CAC-AD
Addiction (Substance Use Disorder)
Addiction (Substance Use Disorder)